You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapse rate

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients With Schizophrenia Trial (Therapeutic Drug Monitoring (TDM) and Pharmacogenetics (PG))

Not yet recruiting
  • Patients With Schizophrenia
  • Therapeutic Drug Monitoring (TDM) and Pharmacogenetics (PG)
  • (no location specified)
May 1, 2023

Asthma Trial in Paris (2: Intervention, 1: Control)

Completed
  • Asthma
  • 2: Intervention
  • 1: Control
  • Paris, France
    Service des Urgences, Hôpital Lariboisière
Mar 9, 2022

Relapsing Remitting Multiple Sclerosis (RRMS) Trial in Tehran (Pegylated interferon beta-1a, Interferon Beta-1A Prefilled

Active, not recruiting
  • Relapsing Remitting Multiple Sclerosis (RRMS)
  • Pegylated interferon beta-1a
  • Interferon Beta-1A Prefilled Syringe
  • Tehran, Iran, Islamic Republic of
    Sina Hospital
Feb 5, 2022

Steroid-Sensitive Nephrotic Syndrome Trial in Islamabad (Prednisolone)

Recruiting
  • Steroid-Sensitive Nephrotic Syndrome
  • Islamabad, Capital, Pakistan
    Pakistan Institute of Medical Sciences
May 9, 2021

Relapse Rate After Allo-HSCT Trial in Shanghai (Flu-Bu-Mel)

Active, not recruiting
  • Relapse Rate After Allo-HSCT
  • Shanghai, China
  • +1 more
Jun 1, 2021

Mass Accumulation Rate asPredictive Biomarker in Multiple

Recruiting
  • Multiple Myeloma in Relapse
    • Duarte, California
    • +5 more
    Jul 13, 2022

    Biochemical Relapse Free Survival, Complications Rates (Erectile Dysfunction, GI, GU Complications) Trial in St Petersburg

    Recruiting
    • Biochemical Relapse Free Survival
    • Complications Rates (Erectile Dysfunction, GI, GU Complications)
    • Stereotactic ablative radiotherapy
    • High dose rate brachytherapy
    • St Petersburg, Russian Federation
      Sergey Novikov
    Apr 28, 2021

    Multiple Myeloma in Relapse Trial in Canada (Daratumumab)

    Completed
    • Multiple Myeloma in Relapse
    • Kingston, Ontario, Canada
    • +5 more
    Feb 14, 2022

    Biochemical Relapse Fo Malignant Tumor of Prostate Trial in Taipei (18F-FACBC PET/CT)

    Recruiting
    • Biochemical Relapse Fo Malignant Neoplasm of Prostate
    • 18F-FACBC PET/CT
    • Taipei, Taiwan
      National Taiwan University Hospital
    Sep 8, 2021

    Neuromyelitis Optica Spectrum Disorder Trial in Isfahan (Azathioprine, Rituximab)

    Completed
    Has Results
    • Neuromyelitis Optica Spectrum Disorder
    • Isfahan, Iran, Islamic Republic of
      Kashani Hospital
    Sep 29, 2020

    Brain Metastases, Small Cell Lung Cancer Trial in Birmingham (NovoTTF-200A, Stereotactic Radiosurgery (SRS))

    Terminated
    • Brain Metastases
    • Small Cell Lung Cancer
    • NovoTTF-200A
    • Stereotactic Radiosurgery (SRS)
    • Birmingham, Alabama
      University of Alabama at Birmingham (UAB), Hazelrig-Salter Radia
    Feb 17, 2022

    Relapse Trial in Aarhus, Oslo (Bonding of either CAD/CAM or conventional multistranded stainless steel fixed retainer)

    Active, not recruiting
    • Relapse
    • Bonding of either CAD/CAM or conventional multistranded stainless steel fixed retainer
    • Aarhus, Denmark
    • +1 more
    Dec 17, 2020

    Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

    Recruiting
    • Hematopoietic Malignancy
    • +2 more
    • Umbilical Cord Blood Transplantation
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow university
    Nov 6, 2023

    Alcohol Use Disorder Trial in Shenzhen (Very brief extinction, Clearly visible extinction, Very brief neutral extinction)

    Not yet recruiting
    • Alcohol Use Disorder
    • Very brief extinction
    • +2 more
    • Shenzhen, Guangdong, China
      Shenzhen Kangning Hospital
    Jul 5, 2023

    ADHD: Gaps Between Alcohol-dependence and Impact on Relapse

    Unknown status
    • Alcoholism
    • Attention Deficit Disorder With Hyperactivity
    • cognitive and psychiatric assessment
    • Lille, France
    • +1 more
    Aug 2, 2019

    Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Genetic Predisposition to Disease
    • Collection of blood sample of bone marrow (cohort 1)
    • Collection of blood sample of bone marrow (cohort 2 and 3)
    • (no location specified)
    Mar 6, 2023

    Smoking Cessation Trial in Hong Kong (Standard smoking cessation treatment, Personalised chat messaging, SMS text messaging)

    Not yet recruiting
    • Smoking Cessation
    • Standard smoking cessation treatment
    • +2 more
    • Hong Kong, Hong Kong
      Tung Wah Group of Hospitals Integrated Centre on Smoking Cessati
    Dec 14, 2022

    Acquired Hemophilia Trial in Tianjin (Daratumumab)

    Recruiting
    • Acquired Hemophilia
    • Tianjin, China
      Chinese Academy of Medical Science and Blood Disease Hospital
    May 5, 2023

    Relapse in Anorexia Nervosa. A Cohort Study

    Recruiting
    • Anorexia Nervosa
      • Garda, Italy
        Department of Eating and Weight Disorders, Villa Garda Hospital
      Apr 27, 2022

      Prophylactic HQP1351 Therapy, Third Generation TKI Trial in Guanzhou (HQP1351( Olverembatinib dimesylate))

      Withdrawn
      • Prophylactic HQP1351 Therapy
      • Third Generation TKI
      • HQP1351( Olverembatinib dimesylate)
      • Guanzhou, China
        Department of Hematology, Nanfang Hospital, Southern Medical Uni
      Jan 16, 2023

      Acute Myeloid Leukemia Trial (MCBC regimen, Bu/Cy regimen)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • MCBC regimen
      • Bu/Cy regimen
      • (no location specified)
      Nov 13, 2023

      Diffuse Large B Cell Lymphoma Trial in Philadelphia (Nivolumab, IV, 240 mg)

      Active, not recruiting
      • Diffuse Large B Cell Lymphoma
      • Nivolumab, IV, 240 mg
      • Philadelphia, Pennsylvania
        Fox Chase Cancer Center
      Jan 3, 2023

      Active tDCS, Sham tDCS Trial in Brussels (tDCS)

      Completed
      • Active tDCS
      • Sham tDCS
      • tDCS
      • Brussels, Belgium
        CHU-Brugmann
      Jul 19, 2022

      MDD, Recurrent, in Remission Trial (Negative ion therapy, Light therapy)

      Not yet recruiting
      • Major Depressive Disorder, Recurrent, in Remission
      • Negative ion therapy
      • Light therapy
      • (no location specified)
      Jul 19, 2022

      Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)

      Recruiting
      • Acute Promyelocytic Leukemia
      • +2 more
      • Beijing, Beijing, China
        Peking University Institute of Hematology
      Apr 26, 2023